Viracta Therapeutics Investors

29 investors on Angel Roster list Viracta Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Israel and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Viracta Therapeutics can appear together.

Investors listed
29
With verified email
31%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 Viracta Therapeutics investors

The most complete profiles first. Showing 29 of 29.

  • Michael HuangVerified

    Venture Capital, Product Operator, Scout · Taiwan

    SeedPre-SeedHealth CareWearablesTelecommunicationsWellness

    Portfolio: Frequency Therapeutics, AEye, Tripresso, Light Field Lab and 12 more

    Verified email available

  • paul klingensteinVerified

    Venture Capital · United States

    Series BSeries AHealth CareWearablesHospitalsWellness

    Portfolio: Alibris, goBalto, Kit Check, Eledon Pharmaceuticals and 32 more

    Verified email available

  • Alon AltschulerVerified

    Venture Capital, Angel Group, Private Equity Firm · United States

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Contact details available

  • Catherine PoulinVerified

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Verified email available

  • James WoodyVerified

    Venture Capital · United States

    Health CareBiotechnologyMarket ResearchMedical

    Portfolio: Calistoga Pharmaceuticals, Pathway Medical Technologies, Femta Pharmaceuticals, Neuraltus Pharmaceuticals and 18 more

    Verified email available

  • Peter FitzgeraldVerified

    Venture Capital · United States

    Health CareBiotechnologyMedicalTherapeutics

    Portfolio: Calistoga Pharmaceuticals, Pathway Medical Technologies, Femta Pharmaceuticals, Neuraltus Pharmaceuticals and 18 more

    Verified email available

  • Richard FerrariVerified

    Venture Capital · United States

    Health CareE-commerceWomen FoundedBiotechnology

    Portfolio: Spiracur, AxoGen, Renovis, Astute Medical and 34 more

    Verified email available

  • Roy WiesnerVerified

    Venture Capital, Angel Group, Private Equity Firm · Israel

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Verified email available

  • Steve SalmonVerified

    Venture Capital · United States

    Health CareBiotechnologyMarket ResearchMedical

    Portfolio: Calistoga Pharmaceuticals, Pathway Medical Technologies, Femta Pharmaceuticals, Neuraltus Pharmaceuticals and 18 more

    Verified email available

  • Stuart CollinsonVerified

    Incubator · United States

    Health CareInformation ServicesInformation Technology (IT)Mobile

    Portfolio: Altair Therapeutics, Nereus Pharmaceuticals, Morphotek, Concurrent Thinking and 25 more

    Verified email available

  • Gur Roshwalb

    Venture Capital, Angel Group, Investor · Israel

    SeedHealth CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 24 more

    Contact details available

  • Todd Sone

    Venture Capital, Angel Group, Private Equity Firm · Israel

    SeedHealth CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 22 more

    Contact details available

  • Alain J. Gilbert

    Private Equity Firm, Investment Partner · France

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Bob Curry

    Venture Capital · United States

    Health CareBiotechnologyMedicalTherapeutics

    Portfolio: Calistoga Pharmaceuticals, Pathway Medical Technologies, Femta Pharmaceuticals, Neuraltus Pharmaceuticals and 18 more

    Contact details available

  • Dorit Sokolov

    Angel Group · Israel

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Contact details available

  • Ed Torres

    Corporate Venture Capital · United States

    Health CareAlternative MedicineWomen FoundedInformation Technology (IT)

    Portfolio: Avid Radiopharmaceuticals, GlobeImmune, Sutro Biopharma, Cerulean Pharma and 30 more

    Contact details available

  • Eran Lerer

    Angel Group · Israel

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Contact details available

  • Fred Dotzler

    Venture Capital · United States

    Health CareE-commerceWomen FoundedBiotechnology

    Portfolio: Spiracur, AxoGen, Renovis, Astute Medical and 34 more

    Contact details available

  • Huang Lee, Ph.D.

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesTelecommunicationsWellness

    Portfolio: Frequency Therapeutics, AEye, Tripresso, Light Field Lab and 9 more

    Contact details available

  • Ita Lu

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesTelecommunicationsWellness

    Portfolio: Frequency Therapeutics, AEye, Tripresso, Light Field Lab and 9 more

    Contact details available

  • Jerome Shen

    Venture Capital, Private Equity Firm · Taiwan

    Health CareWearablesTelecommunicationsWellness

    Portfolio: Frequency Therapeutics, AEye, Tripresso, Light Field Lab and 9 more

    Contact details available

  • Joe Mandato

    Venture Capital · United States

    Health CareE-commerceWomen FoundedBiotechnology

    Portfolio: Spiracur, AxoGen, Renovis, Astute Medical and 34 more

    Contact details available

  • Ken Widder

    Venture Capital · United States

    Health CareBiotechnologyMarket ResearchMedical

    Portfolio: Calistoga Pharmaceuticals, Pathway Medical Technologies, Femta Pharmaceuticals, Neuraltus Pharmaceuticals and 18 more

    Contact details available

  • Lee Steven

    Venture Capital, Private Equity Firm · China

    Health CareWearablesTelecommunicationsWellness

    Portfolio: Frequency Therapeutics, AEye, Tripresso, Light Field Lab and 9 more

    Contact details available

  • Marc

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Omri Strul

    Angel Group · Israel

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Contact details available

  • Victoria Balannik

    Angel Group · Israel

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Contact details available

  • Yaron Daniely

    Angel Group · Israel

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Contact details available

  • Yifat Segev

    Angel Group · Israel

    Health CareHospitalsGeneticsAlternative Medicine

    Portfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Viracta Therapeutics investors are on Angel Roster?

Angel Roster lists 29 Viracta Therapeutics investors. 9 of them (31%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (18), Private Equity Firms (11) and Angel Groups (10). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Viracta Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (3), Series B (1) and Pre-Seed (1).

Where are Viracta Therapeutics investors based?

Most are based in the United States (14), Israel (9) and Canada (2).

Which companies have Viracta Therapeutics investors backed?

The most-backed portfolio companies among them are Mobilion Systems (10), DayTwo (10), Seer (10), Mammoth Biosciences (10) and Scipher Medicine (10).

How do I contact Viracta Therapeutics investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.